This Adobe Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
1
0
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Truist Securities analyst Robyn Karnauskas downgraded the rating for Merck & Co., Inc. (NYSE:MRK) from Buy to Hold and lowered the price target from $130 to $110. Merck shares closed at $101.02 on Tuesday. See how other analysts view this stock.
- Goldman Sachs analyst Alex Scott downgraded American International Group, Inc. (NYSE:AIG) from Buy to …
Full story available on Benzinga.com
Visited 1 times, 1 visit(s) today
Related posts:
- Home Run To Homewrecker – Analyst Cautious On Homebuilders, Downgrades Key Players
- Aclaris Therapeutics’ ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades
- Archer-Daniels-Midland’s Financial Figures ‘Are Too High,’ Analyst Downgrades Stock
- After 130% Surge, AMD Faces Uncertain Road Ahead: Top Analyst Says Chipmaker’s Future Shrouded In Doubt